Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01023204 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer | completed | Phase 2 | 68 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 4, 2010 | clinicaltrials |
| NCT00002707 | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed | completed | Phase 3 | 2,411 | NSABP Foundation IncNETWORK | 2 | Feb 3, 2010 | clinicaltrials |
| PROACT - Pre-Operative Arimidex Compared To Tamoxifen |
| completed |
| Phase 3 |
| 452 |
| AstraZenecaINDUSTRY |
| 10 |
| Feb 3, 2010 |
| clinicaltrials |
| NCT00660803 | Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Jan 21, 2010 | clinicaltrials |
| NCT00604435 | Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | completed | Phase 2 | 69 | Xijing HospitalOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00164658 | Evaluating Tools for Health Promotion and Disease Prevention | completed | Phase 1 | 8,400 | Centers for Disease Control and PreventionFED | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00322504 | Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study | completed | N/A | 10 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00349934 | IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma | completed | Phase 1 | 33 | Immutep S.A.S.INDUSTRY | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00379106 | Arm Function and Quality of Life Following Mastectomy. | completed | N/A | 50 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 70 | City of Hope Medical CenterOTHER | 2 | Jan 6, 2010 | clinicaltrials |
| NCT00721058 | Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer. | completed | N/A | 60 | Maastricht Radiation OncologyOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00304850 | Polyamine-free Diet to Prevent Post Surgery Hyperalgesia(PoLyDOL) | completed | Phase 2 | 160 | University Hospital, BordeauxOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | completed | Phase 3 | 475 | Eli Lilly and CompanyINDUSTRY | 8 | Dec 24, 2009 | clinicaltrials |
| NCT00580086 | Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy | completed | — | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00735215 | Faslodex Registry: Fulvestrant in Current Clinical Practice | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00706069 | Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer | completed | Phase 1 | 40 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT01025349 | Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer | completed | Phase 2 | 20 | Taipei Medical University HospitalOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer | completed | Phase 2 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00237224 | Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | completed | Phase 2 / Phase 3 | 24 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT01016665 | Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy | completed | N/A | 71 | Federal University of São PauloOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00608452 | Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00996632 | The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery(UKBC) | completed | N/A | 94 | University of TriesteOTHER | 1 | Nov 11, 2009 | clinicaltrials |
| NCT00146549 | Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | completed | Phase 3 | 250 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00750464 | Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer | completed | — | 575 | Real Imaging Ltd.INDUSTRY | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00431106 | Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer | completed | Phase 3 | 144 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00002679 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | completed | Phase 2 | 89 | Yale UniversityOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00169000 | Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers | completed | Phase 1 | 12 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00156039 | Randomized Trial of Follow-up Strategies in Breast Cancer | completed | Phase 4 | 968 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00582322 | Genetic Studies in Breast Cancer | completed | — | 483 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 20, 2009 | clinicaltrials |
| NCT00759837 | Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects | completed | Phase 1 | 27 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 16, 2009 | clinicaltrials |
| NCT00638599 | Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer(LMATBBC) | completed | Phase 4 | 200 | Nanjing Medical UniversityOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00940199 | PASSION - P Trial: Ph Adjusted Sulfur-Colloid, Sentinel Initiative ON Pain Trial(PassionP) | completed | — | 140 | Walter Reed Army Medical CenterFED | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00582803 | Adherence to Intensive Surveillance for Hereditary Breast Cancer | completed | — | 85 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00824876 | Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia | completed | — | — | Rigshospitalet, DenmarkOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00606931 | Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities(PEM-BX) | completed | N/A | 22 | Naviscan PET SystemsINDUSTRY | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 4, 2010source: clinicaltrials